The U.S. Meals and Drug Administration late final yr received extra leverage over pharmaceutical corporations that obtained accelerated approvals for his or her medicine. How will the company use its new powers?
Copyright © 2023 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional info.
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content will not be in its last type and could also be up to date or revised sooner or later. Accuracy and availability could fluctuate. The authoritative file of NPR’s programming is the audio file.